Pulmonary aspergillosis: a clinical review

M Kousha, R Tadi, AO Soubani - European Respiratory Review, 2011 - Eur Respiratory Soc
Aspergillus is a mould which may lead to a variety of infectious, allergic diseases depending
on the host9s immune status or pulmonary structure. Invasive pulmonary aspergillosis …

Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches

M Bateman, R Oladele, JK Kolls - Medical mycology, 2020 - academic.oup.com
Pneumocystis jirovecii can cause life-threatening pneumonia in immunocompromised
patients. Traditional diagnostic testing has relied on staining and direct visualization of the …

Galactomannan detection for invasive aspergillosis in immunocompromised patients

MMG Leeflang, YJ Debets‐Ossenkopp… - Cochrane Database …, 1996 - cochranelibrary.com
Background Invasive aspergillosis is the most common life‐threatening opportunistic
invasive mycosis in immunocompromised patients. A test for invasive aspergillosis should …

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - Clinical infectious …, 2008 - academic.oup.com
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

G Maschmeyer, A Haas, OA Cornely - Drugs, 2007 - Springer
Morbidity and mortality caused by invasive Aspergillus infections are increasing. This is
because of the higher number of patients with malignancies treated with intensive …

Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

PL White, JR Wingard, S Bretagne… - Clinical Infectious …, 2015 - academic.oup.com
Background. Aspergillus polymerase chain reaction (PCR) was excluded from the European
Organisation for the Research and Treatment of Cancer/Mycoses Study Group …

Pulmonary aspergillosis: a clinical update

OS Zmeili, AO Soubani - Journal of the Association of Physicians, 2007 - academic.oup.com
Aspergillus spp may cause a variety of pulmonary diseases, depending on immune status
and the presence of underlying lung disease. These manifestations range from invasive …

Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases

J Maertens, V Maertens, K Theunissen… - Clinical infectious …, 2009 - academic.oup.com
Background. Prompt diagnosis of invasive pulmonary aspergillosis (IPA) remains a
challenge. Galactomannan (GM) detection in bronchoalveolar lavage (BAL) fluid by the …

Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid

B Musher, D Fredricks, W Leisenring… - Journal of clinical …, 2004 - Am Soc Microbiol
Invasive pulmonary aspergillosis (IPA) is frequent and often fatal in hematopoietic stem cell
transplant patients. Diagnosis requires microbiological or histopathologic demonstration of …

Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→ 3)-β-d …

M Kawazu, Y Kanda, Y Nannya, K Aoki… - Journal of clinical …, 2004 - Am Soc Microbiol
The establishment of an optimal noninvasive method for diagnosing invasive aspergillosis
(IA) is needed to improve the management of this life-threatening infection in patients with …